Abiopharma

News list

(80% Positive) Mereo BioPharma (MREO) Announces Clinical Development Update (Form 6-K)

Full text

News bot Oct. 18, 2025, 8:41 p.m.
🌍 Mereo BioPharma (MREO) - Form 6-K Filing

Filing Date: 2022-10-18

Accepted: 2022-10-18 07:07:28

Event Type: Clinical Trial Update

Event Details:

Mereo BioPharma Group plc (NASDAQ MREO), (Mereo or the Company) today provided an update to its operating plan and programs. With this go-forward operating plan, Mereo will maintain the ability to progress its core programs, deliver on multiple near-term milestones and maximize value for shareholders. The updated plan extends the Companys cash runway into 2026.
💼 Business Developments:
- ✅ Partnership/Collaboration
- ❌ Acquisition Activity: Not reported
- ✅ Licensing Agreement
- ✅ Regulatory Milestone
- ❌ Leadership Updates: Not reported
📞 Contact Information:
- Email: tbj@abmac.com